Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    1.

    Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

    Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT.

    Diabetes Care. 2004 Apr;27(4):978-83.PMID: 15047659 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

    Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

    Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance.

    Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST.

    Diabetes Care. 2006 Mar;29(3):668-72.PMID: 16505524 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Use of metabolic markers to identify overweight individuals who are insulin resistant.

    McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G.

    Ann Intern Med. 2003 Nov 18;139(10):802-9.PMID: 14623617 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution.

    Jennings CL, Lambert EV, Collins M, Levitt NS, Goedecke JH.

    Metabolism. 2009 Feb;58(2):149-57.PMID: 19154946 [PubMed - indexed for MEDLINE]Related articles

    7.

    Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.

    Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES.

    Diabetes. 2004 May;53(5):1195-200.PMID: 15111486 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cardiometabolic risk among African American women: a pilot study.

    Appel SJ, Oster RA, Floyd NA, Ovalle F.

    J Cardiovasc Nurs. 2009 Mar-Apr;24(2):140-50.PMID: 19242280 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease.

    Ryan MC, Fenster Farin HM, Abbasi F, Reaven GM.

    Am J Cardiol. 2008 Jul 1;102(1):40-6. Epub 2008 May 9.PMID: 18572033 [PubMed - indexed for MEDLINE]Related articles

    11.

    The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.

    Blackburn P, Lemieux I, Alméras N, Bergeron J, Côté M, Tremblay A, Lamarche B, Després JP.

    Metabolism. 2009 Aug;58(8):1123-30. Epub 2009 Jun 18.PMID: 19481769 [PubMed - indexed for MEDLINE]Related articles

    12.

    Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.

    McKenney JM.

    Pharmacotherapy. 2003 Sep;23(9 Pt 2):26S-33S. Review.PMID: 14524636 [PubMed - indexed for MEDLINE]Related articles

    13.

    Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.

    Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.

    Metabolism. 2006 Apr;55(4):445-52.PMID: 16546474 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults.

    Park SH, Lee WY, Rhee EJ, Jeon WK, Kim BI, Ryu SH, Kim SW.

    Clin Sci (Lond). 2005 Jun;108(6):553-9.PMID: 15669921 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.

    Sattar N, Williams K, Sniderman AD, D'Agostino R Jr, Haffner SM.

    Circulation. 2004 Oct 26;110(17):2687-93. Epub 2004 Oct 18.PMID: 15492304 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.

    Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E.

    Metabolism. 2008 Mar;57(3):355-61.PMID: 18249207 [PubMed - indexed for MEDLINE]Related articles

    17.

    Black Hispanics have a worse cardiovascular risk profile than mixed Hispanics in Venezuela.

    Ryder E, Silva E, Sulbarán T, Fernández V, Campos G, Calmon G, Clavell E, Raleigh X, Florez H.

    Invest Clin. 2007 Mar;48(1):45-55.PMID: 17432543 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study.

    Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV; Strong Heart Study.

    Diabetes Care. 2003 Mar;26(3):861-7.PMID: 12610050 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data